These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1447717)

  • 1. Enhanced rectal absorption and reduced local irritation of the anti-inflammatory drug ethyl 4-biphenylylacetate in rats by complexation with water-soluble beta-cyclodextrin derivatives and formulation as oleaginous suppository.
    Arima H; Kondo T; Irie T; Uekama K
    J Pharm Sci; 1992 Nov; 81(11):1119-25. PubMed ID: 1447717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of water-soluble beta-cyclodextrin derivatives as carriers of anti-inflammatory drug biphenylylacetic acid in rectal delivery].
    Arima H; Kondo T; Irie T; Hirayama F; Uekama K; Miyaji T; Inoue Y
    Yakugaku Zasshi; 1992 Jan; 112(1):65-72. PubMed ID: 1578346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the antiinflammatory effect of ethyl 4-biphenylyl acetate in ointment by beta-cyclodextrin derivatives: increased absorption and localized activation of the prodrug in rats.
    Arima H; Adachi H; Irie T; Uekama K; Pitha J
    Pharm Res; 1990 Nov; 7(11):1152-6. PubMed ID: 2293214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible enhancing mechanism of the cutaneous permeation of 4-biphenylylacetic acid by beta-cyclodextrin derivatives in hydrophilic ointment.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Chem Pharm Bull (Tokyo); 1996 Mar; 44(3):582-6. PubMed ID: 8882455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of modified beta-cyclodextrins on pharmacological activity and bioavailability of 4-biphenylacetic acid in rats after oral administration.
    Puglisi G; Ventura CA; Spadaro A; Campana G; Spampinato S
    J Pharm Pharmacol; 1995 Feb; 47(2):120-3. PubMed ID: 7602465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing effect of hydroxypropyl-beta-cyclodextrin on cutaneous penetration and activation of ethyl 4-biphenylyl acetate in hairless mouse skin.
    Arima H; Miyaji T; Irie T; Hirayama F; Uekama K
    Eur J Pharm Sci; 1998 Jan; 6(1):53-9. PubMed ID: 16256708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption enhancement of polypeptide drugs by cyclodextrins. I. Enhanced rectal absorption of insulin from hollow-type suppositories containing insulin and cyclodextrins in rabbits.
    Watanabe Y; Matsumoto Y; Seki M; Takase M; Matsumoto M
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3042-7. PubMed ID: 1477920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
    Minami K; Hirayama F; Uekama K
    J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
    Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
    Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the enhancing effects of cyclodextrins on the solubility and oral bioavailability of tacrolimus in rats.
    Arima H; Yunomae K; Miyake K; Irie T; Hirayama F; Uekama K
    J Pharm Sci; 2001 Jun; 90(6):690-701. PubMed ID: 11357172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
    Uekama K; Minami K; Hirayama F
    J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
    Tanino T; Ogiso T; Iwaki M; Yamaguchi T; Kakehi K
    Biol Pharm Bull; 1999 Oct; 22(10):1099-105. PubMed ID: 10549863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization and in vitro evaluation of dimethyl-beta-cyclodextrin-4-biphenylylacetic acid conjugate.
    Ventura CA; Paolino D; Pedotti S; Pistarà V; Corsaro A; Puglisi G
    J Drug Target; 2003 May; 11(4):233-40. PubMed ID: 14578110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development and pharmaceutical evaluation of hydrophobic cyclodextrin derivatives as modified-release drug carriers].
    Hirayama F
    Yakugaku Zasshi; 1993 Jun; 113(6):425-37. PubMed ID: 8355145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced nasal delivery of luteinizing hormone releasing hormone agonist buserelin by oleic acid solubilized and stabilized in hydroxypropyl-beta-cyclodextrin.
    Abe K; Irie T; Uekama K
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2232-7. PubMed ID: 8582025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heptakis(2,6-di-O-methyl-3-O-acetyl)-beta-cyclodextrin: A water-soluble cyclodextrin derivative with low hemolytic activity.
    Hirayama F; Mieda S; Miyamoto Y; Arima H; Uekama K
    J Pharm Sci; 1999 Oct; 88(10):970-5. PubMed ID: 10514341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some pharmaceutical and inclusion properties of 2-hydroxybutyl-β-cyclodextrin derivative.
    Ishiguro T; Morishita E; Iohara D; Hirayama F; Wada K; Motoyama K; Arima H; Uekama K
    Int J Pharm; 2011 Oct; 419(1-2):161-9. PubMed ID: 21839823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben.
    Tanaka M; Iwata Y; Kouzuki Y; Taniguchi K; Matsuda H; Arima H; Tsuchiya S
    J Pharm Pharmacol; 1995 Nov; 47(11):897-900. PubMed ID: 8708982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced absorption of cyclosporin A by complexation with dimethyl-beta-cyclodextrin in bile duct-cannulated and -noncannulated rats.
    Miyake K; Arima H; Irie T; Hirayama F; Uekama K
    Biol Pharm Bull; 1999 Jan; 22(1):66-72. PubMed ID: 9989664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of PI3K-Akt-Bad pathway in apoptosis induced by 2,6-di-O-methyl-beta-cyclodextrin, not 2,6-di-O-methyl-alpha-cyclodextrin, through cholesterol depletion from lipid rafts on plasma membranes in cells.
    Motoyama K; Kameyama K; Onodera R; Araki N; Hirayama F; Uekama K; Arima H
    Eur J Pharm Sci; 2009 Oct; 38(3):249-61. PubMed ID: 19664706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.